Tavegyl tablets 1 mg blister 20 pcs.

• active ingredient: clemastine;
• 1 tablet contains clemastine fumarate 1.34 mg, which corresponds to 1 mg of clemastine;
• excipients: magnesium stearate, povidone, talc, corn starch, lactose monohydrate.

Hypersensitivity to clemastine or to any of the excipients of the drug, as well as to antihistamines of similar chemical structure; porphyria.

From the nervous system: often – increased fatigue, sedative effect, drowsiness; infrequently – dizziness; rarely – headache.

On the part of the psyche: rarely – excitement (especially in children).

On the part of the digestive system: rarely – gastrointestinal disorders, including epigastric pain, nausea, dry mouth; very rarely – constipation.

From the cardiovascular system: very rarely – tachycardia, feeling of palpitations.

Skin: rarely – skin rashes.

On the part of the immune system: rarely – hypersensitivity reactions, shortness of breath; isolated cases – anaphylactic shock.

General disorders: rarely – asthenia.

The tablets should be taken before meals with water.

Adults and children over 12 years of age should take 1 tablet in the morning and evening. In particularly severe cases, the daily dose can be increased to 6 tablets; the maximum single dose of the drug is 2 tablets.

Children aged 6 to 12 years should be given ½ – 1 tablet before breakfast and at night.

Duration of use of the drug without consulting a doctor is no more than 14 days. Do not exceed the recommended dose. For oral use only.

Tavegyl tablets contain lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.

Tavegyl should be used with caution in patients with a history of epilepsy or seizures, angle-closure glaucoma, peptic ulcer disease with stenosis, pyloroduodenal stenosis, prostatic hypertrophy with urinary retention and bladder neck obstruction. Use with caution in elderly patients who are at higher risk of adverse reactions such as paradoxical excitation, avoiding use in cases of confusion.

Use during pregnancy or breastfeeding

Tavegil should not be prescribed during pregnancy or breastfeeding. Antihistamines can pass into breast milk and affect the newborn.

Children

In this dosage form, the drug should be used in children over 6 years of age.

Ability to influence reaction speed when driving vehicles or other mechanisms

Due to the antihistamine sedative effect of clemastine, the drug may affect the ability to drive vehicles or operate other mechanisms.

Overdose of antihistamines can result in both depression and excitation of the central nervous system (depression, agitation, hallucinations, convulsions). Anticholinergic symptoms (dry mouth, mydriasis, flushing, gastrointestinal disorders, and tachycardia) are also possible.

Treatment consists of removing the drug from the body by gastric lavage, using adsorbents, and conducting symptomatic therapy.

Tavegyl, like other antihistamines, potentiates the sedative effect of CNS depressants (hypnotics, MAO inhibitors, tricyclic antidepressants, anxiolytics, opioid analgesics and alcohol). Clemastine may enhance the effect of some anticholinergics (e.g. atropine, tricyclic antidepressants). Alcoholic beverages should be avoided during use of the drug.

Store out of the reach of children at a temperature not exceeding 30°C.